Metabolic Dysfunction‐Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing‐Risk Cohort Study
Geriatrics & Gerontology International · 2026-11 · 26 (11)
DOI: 10.1111/ggi.70893 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 13.11.2026. Verfasst von Yun Hwan Oh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea. Hauptthemen laut MEDLINE: Atrial Fibrillation, Fatty Liver, Alcohol Drinking. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Seoul Clinical Laboratories.
Abstract (Originalsprache)
Aim
Older adults carry the largest burden of atrial fibrillation (AF) and a high competing risk of death, yet metabolic dysfunction‐associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) have rarely been examined separately in this population. We examined the associations of fatty liver index (FLI)‐defined MASLD and MetALD with incident AF in adults aged ≥ 60 years, accounting for competing death.
Methods
We analyzed 216 292 participants of the Korean National Health Insurance Service‐Senior cohort screened in 2009–2010 without AF recorded before follow‐up. Using FLI ≥ 30 as the phenotype threshold, participants were classified into FLI < 30 reference, MASLD, and MetALD phenotypes. Incident AF was ascertained from claims from 2011 to 2019. Cause‐specific hazard ratios (HRs) were estimated with Cox regression and subdistribution HRs (SHRs) with Fine‐Gray regression; MetALD was compared with MASLD using the ratio of adjusted estimates, and E‐values were computed.
Results
Over 1 833 772 person‐years, 4292 AF events and 25 713 deaths without AF occurred. Compared with the reference phenotype, Model 2 HRs were 1.04 (95% confidence interval [CI], 0.96–1.12) for MASLD and 1.27 (95% CI, 1.09–1.48) for MetALD; SHRs were 1.02 (95% CI, 0.95–1.10) and 1.26 (95% CI, 1.08–1.47). The MetALD estimate was 1.22 times (95% CI, 1.05–1.42) the MASLD estimate. E‐values were 1.23 for MASLD and 1.85 for MetALD.
Conclusions
In older Korean adults, the MASLD‐AF association was uncertain after adjustment, whereas the MetALD association persisted under both cause‐specific and subdistribution hazard frameworks. The MASLD CI included the null, whereas the MetALD estimate was relatively more robust to unmeasured confounding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
- Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea.
- Biomedical Research Center, Korea University Guro Hospital, Seoul, Korea.
- Department of Family Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
ORCID-Profile: Yun Hwan Oh, Eun Seok Kang, Seogsong Jeong, Hyeon Ju Kim
Förderung
- Seoul Clinical Laboratories
Zitieren
APA
Oh, Y. H., Kang, E. S., Jeong, S., & Kim, H. J. (2026). Metabolic Dysfunction‐Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing‐Risk Cohort Study. Geriatrics & Gerontology International, 26(11). https://doi.org/10.1111/ggi.70893
Vancouver
Oh YH, Kang ES, Jeong S, Kim HJ. Metabolic Dysfunction‐Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing‐Risk Cohort Study. Geriatrics & Gerontology International. 2026;26(11). doi:10.1111/ggi.70893
BibTeX
@article{Oh2026,
author = {Oh, Yun Hwan and Kang, Eun Seok and Jeong, Seogsong and Kim, Hyeon Ju},
title = {Metabolic Dysfunction‐Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing‐Risk Cohort Study},
journal = {Geriatrics & Gerontology International},
year = {2026},
volume = {26},
number = {11},
doi = {10.1111/ggi.70893}
}
EUVIMED